• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌的保乳治疗:20年切除加放射治疗经验

Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy.

作者信息

Nakamura Shelley, Woo Carol, Silberman Howard, Streeter Oscar E, Lewinsky Bernard S, Silverstein Melvin J

机构信息

Keck School of Medicine, University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

出版信息

Am J Surg. 2002 Nov;184(5):403-9. doi: 10.1016/s0002-9610(02)01011-5.

DOI:10.1016/s0002-9610(02)01011-5
PMID:12433602
Abstract

BACKGROUND

Breast conservation therapy is a practical alternative to mastectomy for the treatment of ductal carcinoma in situ (DCIS). The role of radiation therapy after excision for DCIS has been debated, however, its value in reducing recurrence has been proven by multiple prospective randomized trials and is well accepted.

METHODS

We examined a prospective database of 260 patients treated for DCIS with excision and radiation from 1979 to 2002. Two different treatment regimens were examined for local recurrence-free survival. Patients treated with radiation therapy 4 days per week were compared with patients treated 5 days per week. The total doses were similar for both groups; boost types differed. Local recurrence as a function of other factors, including nuclear grade, comedonecrosis, and margin width was evaluated.

RESULTS

The median time to local recurrence was 61 months for patients treated 4 days per week compared with 52 months for patients treated 5 days per week (P = not significant). There was no statistical difference in the Kaplan-Meier detailing the probability of local recurrence-free survival for patients treated 4 days per week versus patients treated 5 days per week. Overall, cosmetic results between the two groups were equivalent.

CONCLUSIONS

The comparison of two different radiation treatment regimens shows no difference in local disease-free survival or cosmetic result.

摘要

背景

保乳治疗是治疗导管原位癌(DCIS)时乳房切除术的一种切实可行的替代方案。然而,DCIS切除术后放疗的作用一直存在争议,其在降低复发率方面的价值已被多项前瞻性随机试验证实并得到广泛认可。

方法

我们研究了1979年至2002年期间接受DCIS切除及放疗的260例患者的前瞻性数据库。针对局部无复发生存情况,研究了两种不同的治疗方案。将每周放疗4天的患者与每周放疗5天的患者进行比较。两组的总剂量相似;增强放疗类型不同。评估局部复发与其他因素的关系,包括核分级、粉刺样坏死和切缘宽度。

结果

每周放疗4天的患者局部复发的中位时间为61个月,而每周放疗5天的患者为52个月(P值无统计学意义)。在详细描述每周放疗4天的患者与每周放疗5天的患者局部无复发生存概率的Kaplan-Meier曲线中,无统计学差异。总体而言,两组的美容效果相当。

结论

两种不同放疗方案的比较显示,局部无病生存率或美容效果无差异。

相似文献

1
Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy.导管原位癌的保乳治疗:20年切除加放射治疗经验
Am J Surg. 2002 Nov;184(5):403-9. doi: 10.1016/s0002-9610(02)01011-5.
2
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
3
Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.保乳手术后导管原位癌的常规放疗与低分割放疗的长期疗效比较。
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1017-24. doi: 10.1016/j.ijrobp.2014.07.026. Epub 2014 Sep 11.
4
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
5
Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.保乳手术联合放疗治疗的乳腺导管原位癌患者临床及病理特征与预后的相关性
Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5. doi: 10.1016/s0360-3016(02)03747-1.
6
Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.乳房导管原位癌保乳手术及放疗的病理与技术考量
Ann Oncol. 1999 Aug;10(8):883-90. doi: 10.1023/a:1008339113607.
7
Importance of Surgical Margin Status in Ductal Carcinoma In Situ.手术切缘状态在导管原位癌中的重要性。
Clin Breast Cancer. 2016 Aug;16(4):312-8. doi: 10.1016/j.clbc.2016.02.002. Epub 2016 Feb 12.
8
Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.保乳术后放疗对导管原位癌治疗效果的影响:基于人群的分析。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):491-7. doi: 10.1016/j.ijrobp.2013.02.031.
9
[Ductal carcinoma in situ treated with radiation therapy and additional boost].经放射治疗及追加剂量照射治疗的导管原位癌
Cancer Radiother. 2015 May;19(3):175-9. doi: 10.1016/j.canrad.2015.01.002. Epub 2015 Apr 25.
10
Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.MammoSite球囊近距离放射治疗纯导管原位癌局部乳腺照射的初步结果与评估:一项II期临床研究。
Am J Surg. 2006 Oct;192(4):427-33. doi: 10.1016/j.amjsurg.2006.06.013.

引用本文的文献

1
The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.保乳治疗的导管原位癌女性患者手术切缘与局部复发的相关性:一项荟萃分析
Ann Surg Oncol. 2016 Nov;23(12):3811-3821. doi: 10.1245/s10434-016-5446-2. Epub 2016 Aug 15.
2
Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?保乳手术后,中度风险的导管原位癌是否需要进行放疗?
Springerplus. 2014 Aug 5;3:405. doi: 10.1186/2193-1801-3-405. eCollection 2014.
3
Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study.
影响导管原位癌局部管理质量的因素:一项队列研究。
Curr Oncol. 2013 Jun;20(3):e212-22. doi: 10.3747/co.20.1293.
4
Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.乳腺导管原位癌的保守治疗:意大利多机构回顾性研究结果。
Radiat Oncol. 2012 Oct 25;7:177. doi: 10.1186/1748-717X-7-177.
5
Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.回顾性研究评估 MRI 在早期乳腺癌诊断程序中的作用:MRI 中新病灶与肿瘤病理特征的相关性。
Clin Transl Oncol. 2013 Mar;15(3):205-10. doi: 10.1007/s12094-012-0899-7. Epub 2012 Aug 8.
6
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.乳腺导管原位癌(DCIS)分级对筛检性 DCIS 患者 15 年随访后复发率、类型及时间的影响。
Br J Cancer. 2012 May 8;106(10):1611-7. doi: 10.1038/bjc.2012.151. Epub 2012 Apr 19.
7
Network meta-analysis of margin threshold for women with ductal carcinoma in situ.网络荟萃分析女性导管原位癌的切缘阈值。
J Natl Cancer Inst. 2012 Apr 4;104(7):507-16. doi: 10.1093/jnci/djs142. Epub 2012 Mar 22.
8
Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.导管原位癌女性患者的患者及肿瘤特征与临床结局之间的关联
J Natl Cancer Inst Monogr. 2010;2010(41):121-9. doi: 10.1093/jncimonographs/lgq034.
9
The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.放射治疗在乳腺导管原位癌保守治疗中的作用。
Pathol Oncol Res. 2008 Jun;14(2):179-92. doi: 10.1007/s12253-008-9044-x. Epub 2008 Apr 26.
10
Accelerated partial breast irradiation after conservative surgery for breast cancer.乳腺癌保乳手术后的加速部分乳腺照射
Ann Surg. 2004 Mar;239(3):338-51. doi: 10.1097/01.sla.0000114219.71899.13.